Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05879887 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
MinorTrial completedFinal enrollment: 32 participants (planned 64) · Eligibility criteria revised · Secondary endpoints: details revised at 1 of 3 entries · 1 moreShow 4 more changesShow less
Final enrollment: 32 participants (planned 64)
Eligibility criteria revised
Secondary endpoints: details revised at 1 of 3 entries
Study description revised
MinorPrimary and study completion dates: Jul 30, 2026 to Aug 1, 2026v21
MinorTrial status: Enrolling by Invitation to Active, Not RecruitingPrimary completion date: Mar 30, 2026 to Jul 30, 2026 · Completion date: Apr 1, 2026 to Jul 30, 2026v20Show 2 more changesShow less
Primary completion date: Mar 30, 2026 to Jul 30, 2026
Completion date: Apr 1, 2026 to Jul 30, 2026
MinorPrimary completion date: Mar 1, 2026 to Mar 30, 2026Eligibility criteria shortened, about 22 words · Study description revisedv19Show 2 more changesShow less
MinorPrimary completion date: Dec 1, 2025 to Mar 1, 2026v18
Show 16 earlier versionsHide 16 earlier versions
MinorTrial status: Recruiting to Enrolling by InvitationSite details revisedv17Show 1 more changeShow less
Site details revised
Minor2 versionsRe-verified since Aug 15, 2024, no change to tracked fieldsv15-v16
NotableStart date: Jul 15, 2024 to Aug 15, 2024v14
NotableStart date: May 15, 2024 to Jul 15, 2024v13
MinorStart date: Apr 19, 2024 to May 15, 2024v12
MinorStart date: Mar 25, 2024 to Apr 19, 2024v11
MinorStart date: Feb 26, 2024 to Mar 25, 2024v10
MinorStart date: Feb 15, 2024 to Feb 26, 2024v9
NotableTrial status: Not Yet Recruiting to RecruitingStudy sites: 0 to 1 · Start date: Feb 1, 2024 to Feb 15, 2024v8Show 2 more changesShow less
Study sites: 0 to 1
Start date: Feb 1, 2024 to Feb 15, 2024
NotableStart date: Dec 15, 2023 to Feb 1, 2024v7
NotableStart date: Nov 15, 2023 to Dec 15, 2023v6
NotableStart date: Oct 15, 2023 to Nov 15, 2023v5
NotableStart date: Sep 1, 2023 to Oct 15, 2023Primary completion date: Oct 1, 2025 to Dec 1, 2025 · Completion date: Jan 1, 2026 to Apr 1, 2026v4Show 2 more changesShow less
Primary completion date: Oct 1, 2025 to Dec 1, 2025
Completion date: Jan 1, 2026 to Apr 1, 2026
NotableStart date: Aug 1, 2023 to Sep 1, 2023v3
MinorRe-verified, no change to tracked fieldsv2
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Using a highly innovative methodology, the Multiphase Optimization Strategy (MOST), the purpose of this randomized factorial pilot trial is to identify feasibility, acceptability, and preliminary efficacy of components of an intervention (UPHOLDS) to improve quality of life of older adults with advancing heart failure. Using a 2x2x2x2 factorial design, 64 adults with advancing heart failure will be randomized to receive one or more palliative care coach-delivered components, based on Ferrans' Health-Related Quality of Life Model: 1) psychoeducation on palliative care principles (4 vs. 8 sessions); 2) financial coaching (yes vs. no); 3) one-time specialty outpatient palliative care consultation (yes vs. no); and monthly follow (1 monthly follow-up call vs. monthly follow-up calls for 24 weeks).